NaturalPedia > Patents

Quotes about Patents from the world's top natural health / natural living authors

Share Bookmark and Share  Email to a friend   |  Click here for FREE email alerts

page 1 of 7 | Next ->

"The pharmaceutical industry enjoys monopoly status through the FDA drug approval process and through long-lived patents. FDA's process restricts to single players the right to sell specific drugs. It does so through prior restraint on the right to market, the costly and politically sensitive FDA pre-market drug approval process. Pharmaceutical companies also enjoy statutorily extended patents that provide between 13.9 and 15.4 years of monopoly protection for their FDA-approved drugs."
- Jonathan W. Emord, The Rise of Tyranny (Get the book.)

"Pfizer owns multiple patents, which protect its proprietary interests in the drug. These patents are set to expire sometime between 2011 and 2013. Of course there are a few side effects to the use of the drug. During testing of Viagra, patients reported problems with headache, rash, flushing of the skin, stomachaches, urinary tract infections, dizziness, diarrhea, and vision problems including blurriness and an inability to properly perceive light changes.23 The vision problems restricted the user's ability to use heavy machinery and to drive a car."
- Kenneth W Thomas, Ron Gilbert, Gerd Schaller, Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel (Get the book.)

"The industry has also won new laws that have added years to the average length of time their products are protected from competition by patents. Another law allowed the companies to profit from medical discoveries made by taxpayer-funded scientists. And when these new measures boosted the drug companies' profits, other laws gave them tax credits so lucrative that as a group they pay far lower taxes on average than other major industries. Overall, the pharmaceutical industry has created a market for its products in the United States in which ordinary economics no longer apply."
- Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"In order to keep making money, drug companies are under enormous pressure to create new drugs they can patent and sell without competition for twenty years, after which patents run out and generic (cheaper) versions go to market. In fact, there really aren't a lot of truly new drugs being developed these days. Most pharmaceuticals touted as new are essentially the same as other drugs in their class, with a slight chemical modification that allows the company to have a unique patent. These are called "me-too" drugs."
- J. Douglas Bremner, Before You Take that Pill: Why the Drug Industry May Be Bad for Your Health (Get the book.)

"I also hold patents on numerous other devices to repair leaky heart valves or "sew" new blood vessels into the heart without sutures. Together, my colleague Leonard Bailey and I have performed more infant and pediatric heart transplants than anyone in the world. My laboratory holds the record for producing the longest surviving pig-to-baboon heart transplant—twenty-eight days-when others claimed it could last only hours."
- Dr. Steven R. Gundry, Dr. Gundry's Diet Evolution: Turn Off the Genes That Are Killing You - And Your Waistline - And Drop the Weight for Good (Get the book.)

"He convinced George Merck to relinquish the company's patents to a university trust fund, which then licensed the right to make the antibiotic to several companies. Merck was still the first company to sell streptomycin in 1946, but the price of the drug plunged as other manufacturers joined in. Some writers and historians trace the pharmaceutical industry's interest in science to a 1938 law that was passed to protect the public from ineffective and dangerous medicines. As the writer Philip J."
- Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"That same year the Supreme Court unleashed a deluge of industrial science by allowing the first patent to be placed on a living organism, a bacterium genetically engineered by a scientist at General Electric to devour oil spilled into the sea. patents are vital to industry. They give inventors monopolies on products by preventing competitors from selling them for twenty years. The Supreme Court's ruling reversed that of the U.S. Patent Office, which had long held that living things could not be patented. The decision opened the door to the patenting of genes, cell lines, tissues, and organs."

- Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"In 1997 alone, researchers at Stanford University filed 128 new patents, created fifteen companies, and earned $52 million from licenses on products. Hundreds of academic scientists, including many who had once looked at the pharmaceutical industry with skepticism, walked down from their ivory towers and into the boardrooms of corporate America. The role of the academic as referee to the drug companies' clinical trials became a minor one. And the moderating force that had kept scientific studies honest and impartial began to disappear."

- Melody Petersen, Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves into Slick Marketing Machines and Hooked the Nation on Prescription Drugs (Get the book.)

"Entrepreneurs issued patents for its use as an appetite stimulant, appetite suppressant and anorexic agent. Major corporations such as Unilever in the Netherlands and the International Minerals and Chemicals Corporation in Illinois (makers of Ac'cent—MSG) undertook studies, but eventually gave up on the fruit because they found the active ingredient too complex to stabilize and synthesize. It looked like yet another example of WAWA, an acronym for the region's many business failures: West Africa Wins Again."
- Adam Leith Gollne, The Fruit Hunters: A Story of Nature, Adventure, Commerce and Obsession (Get the book.)

"Get Fit Foods recently filed for patents on presliced apples containing natural flavors. "I think the mind is more accepting when it's natural flavoring," says McHaney. Apple Sweets, as McHaney's product is called, have been tested with forty different so-called natural flavors, such as caramel, root beer and wild berry, and are already being launched in supermarkets. Posterity will determine whether flavored fruits are here to stay. For now, as the Grapple's sales testify, shoppers have cottoned to the novelty factor."

- Adam Leith Gollne, The Fruit Hunters: A Story of Nature, Adventure, Commerce and Obsession (Get the book.)

"C&O Nursery has more than twenty fruit patents, starting with 1932's Plant Patent #51 for the fuzzless Candoka Peach up to 2001's PP #12098 for their striped Top Export Fuji Apples. The family's latest patent, for "grape-flavored pome fruits," is still pending, as anyone trolling the databases of the United States Patent & Trademark Office can see. Everything relating to the Grapple's manufacture is contained in the various dockets of Patent Application #20050058758, filed by Gary Snyder. The documents describe how MA is absorbed through the lenticels."

- Adam Leith Gollne, The Fruit Hunters: A Story of Nature, Adventure, Commerce and Obsession (Get the book.)

"The "gold rush" for nanotechnology patents continues, with more than 4,000 US patents issued to date, Kimbrell reported. More than $32 billion in nano-products were sold in 2005, twice the amount as in 2004. There are now more than 200 self-identified nano-products on US shelves, including paints, sporting goods, sunscreens, cosmetics, stain-resistant clothing, cell phones and digital cameras. The personal care industry is leading the way as the largest single category."
- Stacy Malkan, Not Just a Pretty Face: The Ugly Side of the Beauty Industry (Get the book.)

"According to PhRMA, the effective life of patents after drugs come on the market is about 11 to 12 years. Schering-Plough was unsuccessful in its final attempt to extend its patent on Claritin. The manufacturer's argument went like this: it still owned the patent on the chemical into which Claritin is metabolized after being taken (sold as Clarinex). Therefore, Schering-Plough argued, its patent would be infringed if people were allowed to swallow a generic form of Claritin and metabolize it into a chemical on which Schering-Plough still held the patent. The U.S."
- John Abramson, Overdosed America: The Broken Promise of American Medicine (P.S.) (Get the book.)

"The act stipulates that pharmaceutical companies can extend the patents on their drugs by six months if they do studies on their effectiveness in children. This was and is an important incentive for companies to do research studies on their drugs in children, even if no rationale exists for using the drugs for children. Often these studies are done quickly and are not carefully designed, and their results are not published. This has become a particular issue in the case of treating childhood depression with SSRIs."
- J. Douglas Bremner, Before You Take that Pill: Why the Drug Industry May Be Bad for Your Health (Get the book.)

"The "gold rush" for nanotechnology patents continues, with more than 4,000 US patents issued to date, Kimbrell reported. More than $32 billion in nano-products were sold in 2005, twice the amount as in 2004. There are now more than 200 self-identified nano-products on US shelves, including paints, sporting goods, sunscreens, cosmetics, stain-resistant clothing, cell phones and digital cameras. The personal care industry is leading the way as the largest single category."
- Stacy Malkan, Not Just a Pretty Face: The Ugly Side of the Beauty Industry (Get the book.)

"Drug companies rely so much on profit generated from drugs, especially new ones attached to active patents, that they've begun persuasive marketing campaigns targeting consumers direcuy. In doing so, many times they will angle an ad to make you think you need this pill or that potion to live a healthier, longer life (as in "Ask your doctor if X is right for you.""
- Brenda Watson and Leonard Smith, The Detox Strategy: Vibrant Health in 5 Easy Steps (Get the book.)

"Moreover, in today's world where people do a lot of self-medicating with over-the-counter drugs (more of which continue to spill onto the market as drug companies lose patents and the FDA loosens its rules on what should be prescribed or not), the risk for unwittingly overburdening your body is much bigger. Add to that the fact we'd like to think anything over-the-counter is "safe" and we've got ourselves a recipe for disaster."

- Brenda Watson and Leonard Smith, The Detox Strategy: Vibrant Health in 5 Easy Steps (Get the book.)

"Since 1997, Benveniste and his DigiBio colleagues have filed three patents on diverse applications. For Benveniste the biologist, the applications, naturally enough, were medical. He believed his discovery could open the way for an entirely new digital biology and medicine, which would replace the current clumsy hit-and-miss method of taking drugs. It occurred to him that if you don't need the molecule itself, but only its signal, then you don't need to take drugs, do biopsies or test for toxic substances or pathogens such as parasites and bacteria with physical sampling."
- Lynne Mctaggart, The Field - The Quest for the Secret Force of the Universe (Get the book.)

"All their patents were accepted with the explanation that the ultimate source of energy 'appears to be the zero-point radiation of the vacuum continuum'.y Hal and Ken's discoveries were given an unexpected boost when the Pentagon, which rates new technologies in order of importance to the nation, listed condensed-charge technology, as zero-point energy research was then termed, as number 3 on the National Critical Issue List, only after stealth bombers and optical computing. A year later, condensed-charge technology would move into the number two slot."

- Lynne Mctaggart, The Field - The Quest for the Secret Force of the Universe (Get the book.)

"First patents issued to Dr. Foker on the use of D-ribose to treat ischemic tissue. 1989 Dr. Manfred Gross (Germany) conducts first human clinical study involving ribose treatment for myoadenylate deaminase deficiency. 1991 Dr. Neal Perlmutter (United States) uncovers role of ribose for unmasking hibernating myocardium using thallium-201 imaging. First human study on ribose in heart disease. 1992 Dr. Wolfgang Pliml (Germany) shows the benefit of ribose in improving exercise tolerance in patients with coronary artery disease."
- Stephen T. Sinatra, M.D., The Sinatra Solution Metabolic Cardiology (Get the book.)

"U.S. patents issued for the use of ribose to treat ischemic tissue. More patented applications for ribose therapy were to follow. The first organized clinical trial of ribose in human subjects was reported in 1989. This study showing the effect of ribose in patients with the genetic muscle disorder myoadenylate deaminase disease (MAD), was overwhelmingly positive."

- Stephen T. Sinatra, M.D., The Sinatra Solution Metabolic Cardiology (Get the book.)

"He has authored over 400 original publications, book chapters, and medical books, and has received several patents. He performs over 300 heart operations annually. Dr. Oz is the health expert on The Oprah Winfrey Show. He is chief medical consultant to Discovery Communications and has hosted several shows including Second Opinion with Dr. Oz and Life Line. His "Transplant!" series on Discovery Health Channel won both a FREDDIE and a Silver TELLY award in September 2006. In addition to numerous appearances on network morning and evening news programs. Dr."
- Deirdre Imus, Growing Up Green: Baby and Child Care: Volume 2 in the Bestselling Green This! Series (Green This!) (Get the book.)

"His answers are peppered with talk of pending patents, levels of confidentiality and intellectual property issues. "We're in experimental lockdown," he says. "I have to tiptoe around what I'm saying and hem and haw about what information is released. My partners and I have signed over one hundred fifty NDAs [nondisclosure agreements] on this." When I first contacted Snyder, he said, "No way on God's green earth will I let you into the plant."
- Adam Leith Gollne, The Fruit Hunters: A Story of Nature, Adventure, Commerce and Obsession (Get the book.)

"Amazingly, even though both of the Merck patents were granted in 1990, the company has neither exercised the patents nor educated physicians or patients about the necessity of taking coenzyme Q10 along with statin drugs. The end result is that most doctors and their patients remain completely ignorant that failure to supplement statin drugs with coenzyme Q10 may have potentially life-threatening consequences. CoQIO, by the way, is not the only important antioxidant depleted by statin use."
- Anthony Colpo, The Great Cholesterol Con: Why Everything You've been Told About Cholesterol, Diet and Heart Disease is Wrong (Get the book.)

"The real motivator behind the multinational food conglomerates' creation of GMOs are patents and the monopolistic fortunes they bring. In the summer of 2005, Monsanto filed several patents on the pig—specifically, its gene sequence. It's sheer madness. A significant symptom of an upside-down world is when millions of people are overfed and simultaneously malnourished. Instead of nutritious food provided by the bounty of the earth, we consume high-calorie food invented in laboratories. But our relationship to food is in the process of a huge flip."
- David H. Rippe, Jared Rosen, The Flip: Turn Your World Around (Get the book.)

"There are millions of cosmetics patents, and not one has any meaning when it comes to effectiveness. This is because patents are granted for formulation procedures or for use claims, not because the products can really do something. Variations and potential uses are endless (which is why there are millions of patents), but the basic fact is that a patent doesn't have anything to do with effectiveness, only with the specifics of the formula."
- Paula Begoun, Don't Go Shopping for Hair-Care Products Without Me (Get the book.)

"There are also no patents that deal with proof of efficacy. All a patent can legally do is attribute to an ingredient or formulation the capability to be used for a specific purpose (such as wrinkles, acne, exfoliation, or skin-lightening). That has nothing to do with whether or not those ingredients can do anything at all. patents also do not indicate or validate the quality, reliability, or usefulness of a product, nor does a patent mean that certain established ingredients can't be used by other companies for other purposes (Source: United States Patent and Trademark Office, www.uspto.gov)."
- Paula Begoun and Bryan Barron, Don't Go to the Cosmetics Counter Without Me, 7th Edition (Get the book.)

"In theory, the growing awareness of the need and importance of quality RCT research combined with the expiration of the patents for all the antidepressants and antipsychotics in current use should mean that the use of these drugs will be greatly diminished before long. (Remember that drug patents are awarded for only 20 years from the time the drug patent is submitted.5) After all, once a drug's patent expires and generics become available, the drug companies should no longer be willing to spend the vast sums promoting the chemical imbalance view as they did in the past."
- Dr. Timothy Scott, America Fooled: The Truth About Antidepressants, Antipsychotics and How We've Been Deceived (Get the book.)

"These patents are set to expire sometime between 2011 and 2013. Of course there are a few side effects to the use of the drug. During testing of Viagra, patients reported problems with headache, rash, flushing of the skin, stomachaches, urinary tract infections, dizziness, diarrhea, and vision problems including blurriness and an inability to properly perceive light changes.23 The vision problems restricted the user's ability to use heavy machinery and to drive a car. An 18-page-long package insert accompanies the drug."
- Kenneth W Thomas, Ron Gilbert, Gerd Schaller, Side Effects: The Hidden Agenda of the Pharmaceutical Drug Cartel (Get the book.)

"Network executives saw the pharmaceutical industry as a vast, untapped source of ad revenue, while ad agencies viewed direct-to-consumer ads as their clients' best hope for extracting as much profit as possible from their drugs before their patents ran out. By the early 1990s, pharmaceutical executives, who only a few years before had been aghast at the idea of pushing their drugs on the public, had come around to the notion that patients might even benefit from advertising—that consumers had a right to know about drugs."
- Shannon Brownlee, Overtreated: Why Too Much Medicine Is Making Us Sicker and Poorer (Get the book.)

page 1 of 7 | Next ->

FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.

TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalPedia.com

This unique compilation of research is copyright (c) 2008, 2009 by the non-profit Consumer Wellness Center.

ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of NaturalPedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.

Subscribe to NaturalPedia.com News to receive announcements
Enter your email address:
Email announcements powered by Campaign Enterprise from ArialSoftware.com

Refine your search
with Patents…

Related Concepts:

Patent
Drug
New
Companies
Drugs
Company
Fda
Research
Time
Generic
Plant
Industry
Process
Drug Companies
World
Human
People
Cancer
Market
Products
Food
Public
Monsanto
Genes
Chinese
Gene
Plants
Work
Clinical
Product
Orange
Seed
Example
Effects
Seeds
Corporations
United States
Golden Rice
Health
Medical
Medicine
Golden
Herbal
Farmers
Technology
International
Rights
Marketing
Inventions
Competition
Chemical
Office
Profits
Pills
Brand-name
Disease
Nature
Life
Natural
Poor
Science
Pharmaceutical Industry
Free
American
Herbs
Protection
Body
Children
Western
Effect
Root
Original
Ingredients
Wan
Development
Corporate
Formula
List
Business
Taking
Government
Basmati
Prescription
Scientific
Report
Secondary
Results
America
Intellectual Property
Insulin
Cells
Little
Conditions
Novel
Chemicals
Formulas
Pharmaceutical Companies
Therapy
Foods
Neem

This site is part of the Natural News Network © 2009 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.